Literature DB >> 11565607

Melatonin treatment enhances the efficiency of mice immunization with Venezuelan equine encephalomyelitis virus TC-83.

B Negrette1, E Bonilla, N Valero, H Pons, J Garcia Tamayo, L Chacín-Bonilla, S Medina-Leendertz, F Añez.   

Abstract

To determine whether treatment with melatonin (MLT) improves the efficiency of immunization against Venezuelan equine encephalomyelitis (VEE) virus, mice were vaccinated with TC-83 VEE virus and treated daily with MLT (1 or 5 mg/kg) starting 3 days before immunization, until 10 days after. IgM antibody titers were determined at days 7, 14, and 21 post-immunization. IL-10 levels were assayed at day 14 postvaccination. Treatment with MLT increased antibody titers 14 days after the immunization. IL-10 levels also increased with MLT treatment (1 and 5 mg/kg). Mice were challenged with live VEE virus at day 21 postimmunization, and viral titers were plaque assayed in chicken embryo fibroblasts 4 days after the infection. Following this challenge brain virus levels were significantly reduced. The results suggest that MLT treatment enhances the efficiency of mice immunization against VEE virus.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11565607     DOI: 10.1023/a:1011645400123

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  13 in total

1.  Melatonin protects mice infected with Venezuelan equine encephalomyelitis virus.

Authors:  E Bonilla; N Valero-Fuenmayor; H Pons; L Chacín-Bonilla
Journal:  Cell Mol Life Sci       Date:  1997-05       Impact factor: 9.261

2.  Host defenses during primary Venezuelan equine encephalomyelitis virus infection in mice. I. Passive transfer of protection with immune serum and immune cells.

Authors:  S G Rabinowitz; W H Adler
Journal:  J Immunol       Date:  1973-05       Impact factor: 5.422

3.  Plaque formation by arboviruses.

Authors:  G H Bergold; R Mazzali
Journal:  J Gen Virol       Date:  1968-03       Impact factor: 3.891

4.  High-affinity binding of melatonin by human circulating T lymphocytes (CD4+).

Authors:  M G Gonzalez-Haba; S Garcia-Mauriño; J R Calvo; R Goberna; J M Guerrero
Journal:  FASEB J       Date:  1995-10       Impact factor: 5.191

5.  Enzyme-linked immunosorbent assay detection of immunoglobulins G and M to Venezuelan equine encephalomyelitis virus in vaccinated and naturally infected humans.

Authors:  R R Rosato; F F Macasaet; P B Jahrling
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

6.  Protective effects of melatonin in mice infected with encephalitis viruses.

Authors:  D Ben-Nathan; G J Maestroni; S Lustig; A Conti
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

7.  Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes.

Authors:  F Rousset; E Garcia; T Defrance; C Péronne; N Vezzio; D H Hsu; R Kastelein; K W Moore; J Banchereau
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

Review 8.  A review of the evidence supporting melatonin's role as an antioxidant.

Authors:  R J Reiter; D Melchiorri; E Sewerynek; B Poeggeler; L Barlow-Walden; J Chuang; G G Ortiz; D Acuña-Castroviejo
Journal:  J Pineal Res       Date:  1995-01       Impact factor: 13.007

Review 9.  T-helper-2 lymphocytes as a peripheral target of melatonin.

Authors:  G J Maestroni
Journal:  J Pineal Res       Date:  1995-03       Impact factor: 13.007

10.  Role of the pineal gland in immunity. Circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect of corticosterone.

Authors:  G J Maestroni; A Conti; W Pierpaoli
Journal:  J Neuroimmunol       Date:  1986-11       Impact factor: 3.478

View more
  8 in total

Review 1.  The role of melatonin in immuno-enhancement: potential application in cancer.

Authors:  Sandra C Miller; S R Pandi-Perumal; Perumal S R Pandi; Ana I Esquifino; Daniel P Cardinali; Georges J M Maestroni
Journal:  Int J Exp Pathol       Date:  2006-04       Impact factor: 1.925

2.  In vitro, melatonin treatment decreases nitric oxide levels in murine splenocytes cultured with the venezuelan equine encephalomyelitis virus.

Authors:  Nereida Valero; Eddy Meleán; Ernesto Bonilla; Julia Arias; Luz Marina Espina; Leonor Chacin-Bonilla; Yraima Larreal; Merybell Maldonado; Florencio Añez
Journal:  Neurochem Res       Date:  2005-11       Impact factor: 3.996

3.  Melatonin decreases nitric oxide production, inducible nitric oxide synthase expression and lipid peroxidation induced by Venezuelan encephalitis equine virus in neuroblastoma cell cultures.

Authors:  Nereida Valero; Luz Marina Espina; Jesus Mosquera
Journal:  Neurochem Res       Date:  2006-06-28       Impact factor: 3.996

4.  Emerging issues in COVID-19 vaccination in Tropical Areas: Impact of the Immune Response against Helminths in Endemic Areas.

Authors:  Leonor Chacin-Bonilla; Nathalie Chacón-Fonseca; Alfonso J Rodriguez-Morales
Journal:  Travel Med Infect Dis       Date:  2021-05-26       Impact factor: 6.211

5.  Exogenous melatonin reduces somatic cell count of milk in Holstein cows.

Authors:  Minghui Yang; Jianmin Shi; Jianhua Tian; Jingli Tao; Menglong Chai; Jing Wang; Zhiyuan Xu; Yukun Song; Kuanfeng Zhu; Pengyun Ji; Guoshi Liu
Journal:  Sci Rep       Date:  2017-02-27       Impact factor: 4.379

6.  Effects of Photoperiod Change on Melatonin Secretion, Immune Function and Antioxidant Status of Cashmere Goats.

Authors:  Chenyu Mao; Yuanqing Xu; Lulu Shi; Shiwei Guo; Xiao Jin; Sumei Yan; Binlin Shi
Journal:  Animals (Basel)       Date:  2019-10-06       Impact factor: 2.752

Review 7.  CD147-spike protein interaction in COVID-19: Get the ball rolling with a novel receptor and therapeutic target.

Authors:  Tapan Behl; Ishnoor Kaur; Lotfi Aleya; Aayush Sehgal; Sukhbir Singh; Neelam Sharma; Saurabh Bhatia; Ahmed Al-Harrasi; Simona Bungau
Journal:  Sci Total Environ       Date:  2021-12-01       Impact factor: 7.963

Review 8.  Melatonin and viral infections.

Authors:  Ernesto Bonilla; Nereida Valero; Leonor Chacín-Bonilla; Shirley Medina-Leendertz
Journal:  J Pineal Res       Date:  2004-03       Impact factor: 13.007

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.